Featured insights The latest at the Foundation Insights from our industry-shifting research and analysis, coverage in the international media, events, and all the latest from the Access to Medicine Foundation. News More superbugs, fewer drugs. How can pharma companies ensure the handful of promising antimicrobials make it to the frontlines of drug resistance? 23 May 2024 News Latest Amsterdam Session identifies strategies to accelerate expansion of diabetes care in LMICs 07 May 2024 News New 2024 Index Methodology places greater focus on measuring patient reach 10 October 2023 Featured News Foundation's new report reveals what pharma companies can do to ensure their products reach underserved populations 10 September 2024 Resource Center Explore our research reports and publications Featured News First-of-its-kind framework to assess how generics manufacturers expand access to medicine 15 February 2023 Event Joint event with World Economic Forum on the evolving role of generics – Meeting Report 21 June 2023 News Foundation names Expert Review Committee for 2024 Access to Medicine Index 18 July 2023 Research How companies perform on ensuring access to their SRHR-related products for women and girls in LMICs 25 November 2022 2022 Ranking GSK in top spot, Johnson & Johnson close second. AstraZeneca leaps up to join the top three. Bayer and Merck climb the Index ranking. Read more Featured Media Combating superbugs: How Indian drugmakers can address the global shortfall in antibiotic development 06 June 2024 Media Pharma must ramp up access, stewardship efforts in AMR research, new report finds 23 May 2024 Media Op-ed: There are far too many avoidable deaths in childbirth 18 January 2024 Achievements so far Read more about the Foundation's impact Workshop Closing the gaps in access to diabetes care in low- and middle-income countries 07 July 2022 News Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries 16 June 2021